Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin

Journal of Peptide Research

Volumn 54, Issue 1, 1999, Pages 74-84

  Vogen, S M ^a   Prakash, O ^b   Kirnarsky, L ^a   Sanderson, S D ^a   Sherman, Simon A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

turn; turn; Agonist; Human C5a; Nuclear magnetic resonance

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A; POLYPEPTIDE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; COMPLEMENT C5A; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; OLIGOPEPTIDES; PROTEIN CONFORMATION;

EID: 0005189315     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.1999.00087.x     Document Type: Article

References (26)

1. 1. Hugli, T.E. (1981) The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit. Rev. Immunol. 114, 321-366.
2. 2. Morgan, E.L., Weigle, W.O. & Hugli, T.E. (1984) Anaphylatoxin-mediated regulation of human and murine immune responses. Fed. Proc. 43, 2543-2547.
3. 3. Morgan, E.L., Sanderson, S.D., Scholz, W., Noonan, D.J., Weigle, W.O. & Hugli, T.E. (1992) Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148, 3937-3942.
4. 4. Ember, J.A., Sanderson, S.D., Taylor, S.M., Kawahara, M. & Hugli, T.E. (1992) Biologic activity of synthetic analogues of C5a anaphylatoxin. J. Immunol. 148, 3165-3173.
5. 5. Ember, J.A., Sanderson, S.D., Hugli, T.E. & Morgan, E.L. (1994) Induction of IL-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144, 393-403.
6. 6. Sanderson, S.D., Kirnarsky, L., Sherman, S.A., Ember, J.A., Finch, A.M. & Taylor, S.M. (1994) Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic response and platelet aggregatory activities. J. Med. Chem. 37, 3171-3180.
7. 7. Sanderson, S.D., Kirnarsky, L., Sherman, S.A., Vogen, S.M., Prakash, O., Ember, J.A., Finch, A.M. & Taylor, S.M. (1995) Decapeptide agonists of human C5a: the relationship between conformation and neutrophil response. J. Med. Chem. 38, 3669-3675.
8. 8. Ni, F., Carpenter, K.A., Ripoll, D.R., Sanderson, S.D. & Hugli, T.E. (1996) Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioaoctive peptides from the C-terminus of human C5a anaphylatoxin. Biopolymers 388, 31-41.
9. 9. Finch, A.M., Vogen, S.M., Sherman, S.A., Kimarsky, L., Taylor, S.M. & Sanderson, S.D. (1997) A biologically active conformer of the effector region of human C5a and the modulatory effects of N-terminal receptor binding determinants on activity. J. Med. Chem. 40, 877-884.
10. 10. Vogen, S.M., Prakash, O., Kirnarsky, L., Sanderson, S.D. & Sherman, S.A. (1998) NMR analysis of a potent decapeptide agonist of human C5a anaphylatoxin. J. Peptide Res. 51, 226-234.
11. 11. Tempero, R.M., Hollingsworth, M.A., Burdick, M.D., Finch, A.M., Taylor, S.M., Vogen, S.M., Morgan, E.L. & Sanderson, S.D. (1997) Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J. Immunol. 158, 1377-1382.
12. 12. Buchner, R.R., Vogen, S.M., Fischer, W., Thoman, M.L., Sanderson, S.D. & Morgan, E.L. (1997) Anti-human kappa opioid receptor antibodies - characterization of site-directed neutralizing antibodies specific for a peptide κR (33-52) derived from the predicted amino-terminal region of the human kappa receptor. J. Immunol. 158, 1670-1680.
13. 13. Floreani, A.A., Heires, A.J., Welniak, L.A., Miller-Lindholm, A., Clark-Pierce, L., Rennard, S.I., Morgan, E.L. & Sanderson, S.D. (1998) Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. J. Immunol. 160, 5073-5081.
14. 14. Buchner, R.R., Hugli, T.E., Ember, J.A. & Morgan, E.L. (1995) Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. J. Immunol. 155, 308-315.
15. 15. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Gotze, O. & Morgan, B.P. (1995) Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155, 4882-4889.
16. 16. Haviland, D.L., McCoy, R.L., Whitehead, W.T., Akama, H,, Molmenti, E.P., Brown, A., Haviland, J.C., Parks, W.C., Perlmutter, D.H. & Wetsel, R.A. (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154, 1861-1869.
17. 17. Wuthrich, K. (1986)NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York.
18. 18. Sherman, S., Sclove, S., Kimarsky, L., Tomchin, I. & Shats, O. (1996) Improvement in accuracy of protein local structure determination from NMR data. J. Mol. Struc. (Theochem.) 368, 153-161.
19. 19. Kirnarsky, L., Shats, O. & Sherman, S. (1997) Improving the efficiency of protein structure determination from NMR. J. Mol. Struct. (Theochem.) 419, 213-220.
20. 20. Güntert, P., Braun, W. & Wüthrich, K. (1991) Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. J. Mol. Biol. 217, 517-530.
21. 21. Dyson, H.J., Rance, M., Houghten, R.A., Lerner, R.A. & Wright, P.E. (1988) Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J. Mol. Biol. 201, 161-200.
22. 22. Siligardi, G. & Drake, A.F. (1995) The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides. Biolpolymers (Peptide Sci.) 37, 281-292.
23. 23. Sherman, S.A., Gmeiner, W.H., Kirnarsky, L., Perini, F. & Ruddon, R.W. (1995) A linear 23-residue peptide reveals a propensity to form an unusual native-like conformation. J. Biomol. Struc. Dyn. 13, 441-446.
24. 24. Smith, J.A. & Pease, L.G. (1980) Reverse turns in peptides and proteins. CRC Crit. Rev. Bioc. 8, 315-399.
25. 25. Lewis, P.N., Momany, F.A. & Scheraga, H.A. (1971) Folding of polypeptide chains in proteins: a proposed mechanism for folding. Proc. Natl Acad, Sci. USA 68, 2293-2297.
26. 26. Vogen, S.M., Finch, A.M., Wadi, S.K., Thatcher, J., Monk, P.N., Taylor, S.M. & Sanderson, S.D. (1999) The influence of Lys68 in decapeptide agonists of C5a on C5a receptor binding, activation, and selectivity. J. Peptide Res. 53, 8-17.